Skip to main content

Animations

MJFF Publications

7281 - 7290 of 9148 Results
Title
Year
  • Year
  • 2026
  • 2026
  • 2026
  • 2026
  • 2026
  • 2026
  • 2022
  • 2023
  • 2013
  • 2026
  • Summary Details
    OPEN
    Title: Construct optimization for AAV-mediated human α-syn overexpression, and validation across research settings: Development of a shared tool for the research community
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1177/1877718x261447105
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Parkinson's disease drug therapies in the clinical trial pipeline: 2015–2024
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1877718x261454154
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Progressive Supranuclear Palsy in India: Insights from a Large Multicenter Clinical Cohort (Project PAIR ‐ PSP )
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.70672
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Functional Blood‐Brain Barrier Crossing by Biomimetic M13 Phage Vectors for Targeted Neuronal Delivery
    Journal Name: Advanced Healthcare Materials
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/adhm.202600029
    Citation Count: 0
  • Outcomes in Long‐Term Follow‐Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers Initiative
    2026
    Summary Details
    RESTRICTED
    Title: Outcomes in Long‐Term Follow‐Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers Initiative
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/ana.78248
    Citation Count: 1
  • Summary Details
    OPEN
    Title: LRRK2 G2019S variant is associated with transcriptional changes in Parkinson’s disease human myeloid cells under proinflammatory environment
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-026-03967-0
    Citation Count: 5
  • Analysis of EEG for Parkinson’s Disease Detection
    2022
    Summary Details
    RESTRICTED
    Title: Analysis of EEG for Parkinson’s Disease Detection
    Journal Name: 2022 IEEE International Conference on Signal Processing and Communications (SPCOM)
    Publisher: IEEE
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1109/spcom55316.2022.9840776
    Citation Count: 8
  • Transdermal Nicotine Treatment and Progression of Early Parkinson’s Disease
    2023
    Summary Details
    RESTRICTED
    Title: Transdermal Nicotine Treatment and Progression of Early Parkinson’s Disease
    Journal Name: NEJM Evidence
    Publisher: Massachusetts Medical Society
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1056/evidoa2200311
    Citation Count: 26
  • Summary Details
    OPEN
    Title: Money without collaboration won't bring cures
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/nm0213-127
    Citation Count: 4
  • New evidence on the clinical, genetic, and biochemical bases of GBA1-Parkinson's disease: prospects for treatment
    2026
    Summary Details
    RESTRICTED
    Title: New evidence on the clinical, genetic, and biochemical bases of GBA1-Parkinson's disease: prospects for treatment
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(26)00090-6
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.